Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00003410 · ClinicalTrials.gov registry record · Phase 1
Motexafin Gadolinium With MRI-Guided Surgery in Treating Patients With High-Grade Gliomas
A Phase 1 study, sponsored by Jonsson Comprehensive Cancer Center.
- Completed
- Registry status
- Phase 1
- Development phase
NCT00003410: Completed Phase 1 study, sponsored by Jonsson Comprehensive Cancer Center.
NCT00003410 is a Phase 1 study that has completed, run by Jonsson Comprehensive Cancer Center. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00003410, a Phase 1 study, has completed, sponsored by Jonsson Comprehensive Cancer Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
RATIONALE: New imaging procedures such as the use of gadolinium texaphyrin with MRI may improve the ability to detect the extent of gliomas. PURPOSE: Phase I trial to study the effectiveness of gadolinium texaphyrin used with MRI-guided surgery in treating patients with high-grade glioma.
Interventions
- DRUG motexafin gadolinium
- PROCEDURE magnetic resonance imaging
- PROCEDURE surgical procedure
Trial Details
| Field | Value |
|---|---|
| Start Date | 1998-07 |
| Est. Completion | 2004-06 |
| Phase | Phase 1 |
What the finished NCT00003410 record still lists
NCT00003410 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 3 interventions - of which motexafin gadolinium is the first listed.
NCT00003410 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00003410 about?
NCT00003410 is a clinical study titled "Motexafin Gadolinium With MRI-Guided Surgery in Treating Patients With High-Grade Gliomas". RATIONALE: New imaging procedures such as the use of gadolinium texaphyrin with MRI may improve the ability to detect the extent of gliomas. PURPOSE: Phase I trial to study the effectiveness of gadolinium texaphyrin used with MRI-guided surgery in treating patients with high-grade glioma.
What is the current status of trial NCT00003410?
This trial is currently completed. It is a Phase 1 study. The study started on 1998-07. Estimated completion is 2004-06.
What interventions are being tested in trial NCT00003410?
The interventions under investigation include: motexafin gadolinium (DRUG), magnetic resonance imaging (PROCEDURE), surgical procedure (PROCEDURE).
Who is sponsoring clinical trial NCT00003410?
This trial is sponsored by Jonsson Comprehensive Cancer Center, which has 321 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia